Last updated on February 2018

A Role for RAGE/TXNIP/Inflammasome Axis in Alveolar Macrophage Activation During ARDS (RIAMA): a Proof-of-concept Clinical Study


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Artificial respiration | ADULT RESPIRATORY DISTRESS SYNDROME
  • Age: Between 18 - 95 Years
  • Gender: Male or Female

Inclusion Criteria:

  • ICU patients without ARDS and under mechanical ventilation for less than 24 hours
  • Patients within the first 24 hours after onset of moderate to severe ARDS according to the 2012 Berlin definition (ARDS group)

Exclusion Criteria:

  • - Pregnancy
  • Acute exacerbation of diabetes (ketoacidosis, hyperosmolar hyperglycemic state)
  • Patient under mechanical ventilation for > 7 days
  • Dialysis-dependent chronic renal failure
  • Alzheimer's disease
  • Amyloidosis
  • Evolutive neoplastic lesion
  • Chronic pulmonary disease requiring long-term oxygen therapy or mechanical ventilation
  • Chemotherapy treatment in the last 30 days
  • Severe neutropenia (<0.5 G/l)

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.